Orion

66.00 EUR

-1.27%

14,380 following

ORNBV

NASDAQ Helsinki

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orion

Q2/25Q3/25Q4/252025Q1/26Q2/26eQ3/26eQ4/26e2026e
Revenue416.5422.8695.31,889.5417.7505.0522.7626.02,071.4
EBITDA118.6135.2344.2689.5130.4168.1193.7274.8766.9
EBIT (adj.)104.6121.0328.1631.6114.8152.5178.1259.2704.5
EBIT104.6121.0328.1631.6114.8152.5178.1259.2704.5
EBIT-% (adj.)25.1 %28.6 %47.2 %33.4 %27.5 %30.2 %34.1 %41.4 %34.0 %
EBIT-%25.1 %28.6 %47.2 %33.4 %27.5 %30.2 %34.1 %41.4 %34.0 %
Profit before taxes103.4120.4327.0627.7113.4151.5177.1258.2700.1
Net income82.596.0260.4500.290.4119.4139.7203.7553.3